UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046704
Receipt number R000053281
Scientific Title Prospective study on the assessment of diagnostic and therapeutic efficacy of FDG-PET/CT with delayed contrast-enhanced CT on cardiac sarcoidosis
Date of disclosure of the study information 2022/01/25
Last modified on 2023/01/24 16:06:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the assessment of diagnostic and therapeutic efficacy using contrast-enhanced FDG-PET/CT for cardiac sarcoidosis

Acronym

The assessment of diagnostic efficacy of contrast-enhanced PET/CT for cardiac sarcoidosis

Scientific Title

Prospective study on the assessment of diagnostic and therapeutic efficacy of FDG-PET/CT with delayed contrast-enhanced CT on cardiac sarcoidosis

Scientific Title:Acronym

The assessment of diagnostic efficacy of PET/CT with delayed contrast-enhanced CT for cardiac sarcoidosis

Region

Japan


Condition

Condition

Cardiac sarcoidosis

Classification by specialty

Cardiology Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to establish a new diagnostic protocol for cardiac sarcoidosis and its clinical application in patients with suspected cardiac sarcoidosis by performing a digital PET/CT with iodine contrast material.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diagnostic performance of late iodine enhancement of myocardium using contrast-enhanced PET/CT

Key secondary outcomes

Determination of efficacy after steroid treatment in areas of active inflammation (FDG accumulation) and myocardial fibrosis (delayed enhancement)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine Device,equipment

Interventions/Control_1

Delayed contrast enhanced CT of myocardium

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients for whom written consent has been obtained from the individual
(2) Patients who can be hospitalized and attend outpatient clinics

Key exclusion criteria

1) Patients who have not been fasting for a long time (more than 18 hours)
2) Patients with renal failure(eGFR <30)
3) Patients with hyperthyroidism
4) Patients who are pregnant or of childbearing potential
5) Patients with allergy to contrast material
6) Patients with bronchial asthma
7) Patients who are judged unsuitable for participation in this study by the investigator for other reasons
(8) Patients with poorly controlled diabetes mellitus

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Kawaguchi
Middle name
Last name Naoto

Organization

Ehime University Graduate School of Medicine

Division name

Department of Radiology

Zip code

791-0295

Address

Shitsukawa,Toon,Ehime

TEL

089-960-5371

Email

n.kawa1113@gmail.com


Public contact

Name of contact person

1st name Kawaguchi
Middle name
Last name Naoto

Organization

Ehime University Graduate School of Medicine

Division name

Department of Radiology

Zip code

791-0295

Address

Shitsukawa,Toon,Ehime

TEL

089-960-5371

Homepage URL


Email

n.kawa1113@gmail.com


Sponsor or person

Institute

Ehime university

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board,Ehime University Hospital

Address

Shitsukawa,Toon,Ehime

Tel

089-960-5172

Email

rinri@m.ehime-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 01 Month 24 Day

Date of IRB

2021 Year 12 Month 28 Day

Anticipated trial start date

2022 Year 01 Month 25 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 01 Month 23 Day

Last modified on

2023 Year 01 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053281